ERD

Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cance...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Clinical Trial 2 EUDRA CT

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Liquid biopsy for rectal cancer: A systematic review

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

TRKA expression and NTRK1 gene copy number across solid tumours

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Combined Low Densities of FoxP3 + and CD3 + Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High R...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Submission of scientific paper for publication and thereby bringing trial results into the public domain CT2

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Clinical Trial 3 EUDRA CT

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Exploiting DNA repair defects in colorectal cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular dom...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic co...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from ...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Evolving neoantigen profiles in colorectal cancers with DNA repair defects

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Inactivation of DNA repair—prospects for boosting cancer immune surveillance

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Liquid Biopsies, What We Do Not Know (Yet)

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Integrating liquid biopsies into the management of cancer

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with r...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients ...

Project: MoTriColor

Updated at: 29-04-2024

Show more information

Project acronym MoTriColor

Resources

Selected filters:

Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cance...

Clinical Trial 2 EUDRA CT

Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions

Liquid biopsy for rectal cancer: A systematic review

TRKA expression and NTRK1 gene copy number across solid tumours

Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor

Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies

Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients

Combined Low Densities of FoxP3 + and CD3 + Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High R...

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer

Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal Cancer

Submission of scientific paper for publication and thereby bringing trial results into the public domain CT2

Clinical Trial 3 EUDRA CT

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer

A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology

Exploiting DNA repair defects in colorectal cancer

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular dom...

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer

HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer

Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic co...

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from ...

Evolving neoantigen profiles in colorectal cancers with DNA repair defects

Inactivation of DNA repair—prospects for boosting cancer immune surveillance

Liquid Biopsies, What We Do Not Know (Yet)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

Integrating liquid biopsies into the management of cancer

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with r...

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients ...